Blog Articles

We started discussing the form our corporate social investment would take well over a year ago.

There enormous growth in perinatal stem cell research, particularly the non-haematological uses of both cord blood and cord tissue stem cells.

Current academic views on cord blood banking are still conservative as the lifetime likelihood of developing a blood-related disease requiring transplantation remains low.

According to a recent article in Live Science, human amniotic membrane biological patches can be used to treat superficial wounds such as partial thickness burn wounds, diabetic foot ulcers, venous leg ulcers and bed sores.

Our Netcells team is proud to announce that we have released a second unit of umbilical cord blood belonging to a three-year-old Netcells baby born with cerebral palsy. 

Expectant parents are faced with a number of decisions before the birth of a baby, among them whether to collect the baby’s umbilical cord blood at birth.

The merger of local leaders in stem cell banking and genetic testing consolidates their position in the African biotechnology industry.

A newborn screening test is done in collaboration with North-West University and includes tests relevant to the South African population. 

Next Biosciences will work closely with CHOC to ensure that any unutilised funds from procedural fees donated by obstetricians will be directed to CHOC, as the Netcells ‘Families of Hope’ programme’s goals are closely aligned to theirs: Keeping more than hope alive.

Winner of first South African Global Impact Competition presents an innovative concept to address HIV/AIDS.